Werner Rubas

Werner Rubas

Company: Sutro Biopharma

Job title: Vice President, Preclinical Development


Unveiling the Differences in Toxicity in NHPs when Using an Identical Linker and Payload but Harnessing Different Targets 9:30 am

Evaluating toxicities in rodents and NHPs with two different linkers Determining the difference in toxicity in NHP for identical linker and payload but different targets Comparing the highest non severely toxic dose of a vcMMAE against b-GLU exatecan in NHP on a high expression targetRead more

day: Conference Day 1

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.